Camber Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Camber Capital Management LLC
CRD #155454
SEC #801-73594
CIK #0001444043
AUM
Employees 10 (60% Investors, 0% Brokers)
Fees
Minimum
Phone617-717-6600
Address101 Huntington Avenue
Boston, MA 02199-8089
Source [IAPD] [EDGAR] [Website]
Total AUM ($B)
3.02.41.81.20.60.02009201420192025
Fees and Compensation — Form ADV Part 2A (6/11/2018) [Brochure]
Item 5: Fees and Compensation

A. Description

         Camber bases its fees and performance compensation upon a percentage of assets under
management and upon performance. Clients typically pay Camber quarterly management fees no
greater than 1.5% per annum of the balance in such Client's account or the net asset value of each
investor’s investment in a Client organized as a pooled investment vehicle. Clients also pay or allocate
to an affiliate of Camber a performance allocation or fee equal to no greater than twenty percent
(20%) of the increase in net asset value of a Client’s account or of the increase in the net asset value
of an investor’s investment in a Client organized as a pooled investment vehicle (after calculation and
accrual of management fees) generally determined as of the last business day of each fiscal year,
subject to a high water mark. Such fees and compensation are currently not negotiable.

B. Fee Billing

         Management fees are deducted quarterly from Clients' assets in advance. Any performance
allocation is deducted annually in arrears (or at the time of withdrawal if such withdrawal occurs prior
to the end of a year) from Clients' assets.

C. Other Fees and Expenses

         Each Client managed by Camber pay or reimburse Camber, as the case may be, for all costs
and expenses related to its investments and its operations, including, without limitation, brokerage
and other transaction costs, clearing and settlement charges, interest and commitment fees on debit
balances or borrowings, borrowing charges on securities sold short, costs of any liability insurance
obtained on behalf of such Client, custody fees, costs of any litigation or investigation involving Client
activities, indemnification expenses, the management fees, consulting expenses, the fees and
expenses of professionals providing services to such Client, including legal, audit, accounting, tax and
administration and director services for Camber's non-U.S. pooled investment vehicles that are
organized as limited companies, any issue or transfer taxes chargeable in connection with any
securities transactions, any entity level taxes, regulatory costs, filing and license fees, the costs of
reporting and providing information and any extraordinary expenses. Camber or one of its affiliates
may elect from time to time to pay certain of a Client's expenses in addition to the organizational
expenses, including, but not limited to, other operating expenses. Please refer to Item 12 for more
information about brokerage.

D. Fees in Advance

        Clients pay management fees quarterly and in advance. Management fees are calculated
based on the balance in each Client's account or net asset value of an investor’s investment in a Client
organized as a pooled investment vehicle as of the beginning of each calendar quarter. An investor
who invests in a pooled investment vehicle managed by Camber who withdraws shall be reimbursed
a pro rata portion of the management fee, if any, based upon the date of withdrawal. In addition, a
managed account Client who terminates its investment management agreement with Camber shall
be reimbursed a pro rata portion of any management fees paid in advance based upon the date of
termination.

E. Securities Compensation

Not applicable.
Account Minimums and Types of Clients — Form ADV Part 2A (6/11/2018) [Brochure]
Item 7: Types of Clients

Description

Camber currently provides investment advisory services and portfolio management on a discretionary
basis for high net worth individuals and pooled investment vehicles.

Account Minimums

The Clients that Camber manage have minimum initial investments of $1,000,000, although when
Camber is accepting new managed accounts or investors in its pooled investment vehicles, Camber
may accept lesser amounts in its sole discretion.
Sector Form 13F Holdings Value ($B)
Zimmer Holdings Inc 0.1
Baxter International Inc 0.1
Humana Inc 0.1
CVS Caremark Corp 0.1
Globus Medical Inc 0.0
Icon PLC /Adr/ 0.0
Ascendis Pharma A/S 0.0
Merck & Co Inc 0.0
GlaxoSmithKline PLC 0.0
Pfizer Inc 0.0
View All
Holdings by Sector ($B)
4.03.22.41.60.80.02012201620212026
Type Form D Funds Date Sold AUM
HF Camber Capital Opportunity Fund LP [2016-07-20] 54.9 M 0.0 M
Filed 2016-06-20 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Camber Capital Fund LP [2012-02-14] 1,205.9 M 655.5 M
Filed 2025-06-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF Camber Capital Offshore Fund Ltd [2012-02-14] 1,629.3 M 764.3 M
Filed 2025-06-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 5 2.6
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 1 0.0
Total 6 2.6
By Discretionary
Discretionary 6 2.6
Non-Discretionary 0 0.0
Total 6 2.6
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 2.6
Total 6 2.6
Form D Directors Role # Filings # Firms 2011 - 2026
Roger Hanson Director 255 86
Alaina Danley Director 111 32
Michael McDonald Director 123 30
Amber Ramsey Director 72 30
Stephen Dubois Director, Executive Officer 4 2
Camber Capital Management LLC Promoter 4 2
Camber Capital Partners LLC Promoter 3 2
Camber Capital Management LP Promoter 3 2
Camber Capital Partners III LLC Executive Officer 1 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001444043]
3 [0001444043]
4 [0001444043]
SC 13D [0001444043]
SC 13G [0001444043]
Form 13D/13G Filer Form 13D/13G Subject Filed
Camber Capital Management LP PTC Therapeutics Inc [2023-10-30]
Camber Capital Management LP Inogen Inc [2023-07-24]
Camber Capital Management LP Orasure Technologies Inc [2023-02-02]
Camber Capital Management LP Solid Biosciences Inc [2022-12-12]
Camber Capital Management LP Quanterix Corp [2022-08-19]
Camber Capital Management LP Myriad Genetics Inc [2022-05-12]
Camber Capital Management LP Zimvie Inc [2022-03-21]
Camber Capital Management LP Orasure Technologies Inc [2021-11-08]
Camber Capital Management LP Orasure Technologies Inc [2021-07-29]
Camber Capital Management LP AVROBIO Inc [2020-11-30]
View All
Firm Profile (Form ADV)
Discretionary AUM$1.7B
ServesInstitutional, Retail
Fund TypesHedge Fund
Form 3/4/5 Subject 2011 - 2026
Camber Capital Management LP
ZimVie Inc
AMAG Pharmaceuticals Inc
Endologix Inc /DE/
Protalix BioTherapeutics Inc
Cardiovascular Systems Inc
Sequenom Inc
World Heart Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
ZimVie Inc ZIMV
Common Stock
2024-08-02 Sell 525,000 $17.71 9,297,750
AMAG Pharmaceuticals Inc AMAG
Common Stock
2020-10-01 Sell 4,390,000 $13.57 59,572,300
AMAG Pharmaceuticals Inc AMAG
Common Stock
2019-08-09 Buy 26,600 $8.94 237,804
AMAG Pharmaceuticals Inc AMAG
Common Stock
2019-08-09 Buy 3,400 $9.18 31,212
AMAG Pharmaceuticals Inc AMAG
Common Stock
2019-08-07 Buy 4,000 $7.58 30,320
AMAG Pharmaceuticals Inc AMAG
Common Stock
2019-08-07 Buy 301,000 $7.79 2,344,790
AMAG Pharmaceuticals Inc AMAG
Common Stock
2019-08-07 Buy 50,000 $7.74 387,000
Protalix BioTherapeutics Inc PLX
Common Stock
2016-12-02 Sell 2,500,000 $0.32 800,000
Cardiovascular Systems Inc CSII
Common Stock
2016-09-20 Sell 57,000 $23.54 1,341,780
Cardiovascular Systems Inc CSII
Common Stock
2016-09-19 Sell 1,043,000 $23.25 24,249,750
Cardiovascular Systems Inc CSII
Common Stock
2016-02-23 Buy 250,000 $7.55 1,887,500
Sequenom Inc SQNM
Common Stock
2016-01-04 Buy 75,000 $1.59 119,250
Sequenom Inc SQNM
Common Stock
2015-12-31 Buy 395,435 $1.64 648,513
Sequenom Inc SQNM
Common Stock
2015-12-30 Buy 195,000 $1.59 310,050
Sequenom Inc SQNM
Common Stock
2015-12-15 Buy 20,000 $1.41 28,200
Sequenom Inc SQNM
Common Stock
2015-12-14 Buy 20,000 $1.26 25,200
Sequenom Inc SQNM
Common Stock
2015-12-14 Buy 428,000 $1.30 556,400
Sequenom Inc SQNM
Common Stock
2015-12-10 Buy 253,565 $1.36 344,848
Sequenom Inc SQNM
Common Stock
2015-12-09 Buy 213,000 $1.32 281,160
Sequenom Inc SQNM
Common Stock
2015-12-08 Buy 325,000 $1.24 403,000
showing 20 of 32 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com